期刊文献+

恶性疟原虫PfEMP-1的研究进展 被引量:1

Research progress in PfEMP-1 of Plasmodium falciparum
下载PDF
导出
摘要 目的恶性疟原虫红细胞表面蛋白-1(PfEMP-1)是由var基因家族编码的一种蛋白质,它是疟原虫在宿主体内存活的重要蛋白。不但参与疟原虫的抗原变异,调节人的免疫应答,而且还是重要的粘附分子。本文对PfEMP-1的基础结构特征及其与临床的病理联系,及以其为基础的抗疟疫苗研发方面的研究进展作一综述。 PfEMP-1 is encoded by members of Pgasmodium falciparurn (P. falciparurn) var gene family. As an im- portant protein of P. falciparurn which live in the host (mosquito and human), it not only involves in the antigen variation and regulation of immune response, but also refers as an important cytoadherence molecule. In this article, PfEMP-1 is reviewed from the basic structure characteristics to the research and clinical application and promotion, and further explains would be given to the theoretical evidence for the feasibility of malaria vaccine development.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2013年第3期290-293,共4页 Chinese Journal of Zoonoses
基金 国家自然科学基金(No.30960050 No.81161120421 No.31260508)~~
关键词 恶性疟原虫 恶性疟原虫红细胞表面蛋白-1 var基因 Plasmodium falciparum PfEMP-1 var gene
  • 相关文献

参考文献32

  • 1WHO. World Malaria Report 2010[R]. World Health Organiza- tion, Geneva, 2011.
  • 2Idro R, Marsh K, John CC, et al. Cerebral malaria: Mecha- nisms of brain injury and strategies for improved neuroeognitive outcome[J]. Pediatr Res, 2010, 68 (4): 267-274. DOI; 10. 1203/PDR. 0b013e3181eee78.
  • 3Losimba Likwela J, D'Alessandro U, Donnen P, et al. Clinical aspects and outcome of suspected severe pediatric malaria [J]. Med Mal Infect, 2012, 42(7) : alS-a20. DOI: 10. 1016/j. med- mal. 2012.05. 008.
  • 4Teferra S, Shibre T. Perceived causes of severe mental illness and preferred interventions by the Borana semi-nomadic popula- tion in southern Ethiopia: a qualitative study[J]. BMC Psychia- try, 2012, 12: 79. DOI: 10. 1186/1471244X-12-79.
  • 5Shahbazfar AA, Zare P, Mohammadpour H, et al. Effects of different concentrations of artemisinin and artemisinin-iron com- bination treatment on Madin Darby Canine Kidney (MDCK) cells[J]. Interdiscip Toxicol, 2012, 5 (1) : 30-37. DOI: 10. 2478/ vi0102-012-0006-5.
  • 6Lacerda MV, Fragoso SC, Alecrim MG, et al. Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill[J]. Clin In- fect Dis, 2012, 55(8): e67-e74. DOI; 10. 1093/cid/cis615.
  • 7Amaratunga C, Lopera-Mesa TM, Brittain NJ, et al. A role for fetal hemoglobin and maternal immune IgG in in{ant resistance to Plasmodiurn falciparum malaria[J]. PLoS One, 2011, 6 (4), e14798. DOI: 10.1371/journal. pone. 0014798.
  • 8Hughes KR, Biagini GA, Craig AG. Continued cytoadherence of Plasrnodium falciparum infected red blood cells after antimalari- al treatment[J]. Mol Biochem Parasitol, 2010, 169(2) : 71-78. DOI: 10. 1016/j. molbiopara. 2009.09. 007.
  • 9Sander AF, Salanti A, Lavstsen T, et al. Positive selection of Plasmodium falciparum parasites with multiple var2csa-type PfEMP1 genes during the course of infection in pregnant women [J]. JInfectDis, 2011, 203(11):1679-1685. DOI: 10.1093/in- dis/iir168.
  • 10Scherf A, Lopez-Rubio JJ, Riviere L. Antigenic variation in Plasmodium falciparum[-J]. Annu Rev Microbiol, 2008, 62: 445-470. DOI: 10. 1146/annurev. micro. 61. 080706. 093134.

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部